Literature DB >> 19540824

Complications of polyacrylamide hydrogel (PAAG) injection in facial augmentation.

H L Liu1, W Y Cheung.   

Abstract

Polyacrylamide hydrogel (PAAG) has been used as an injectable filler for soft tissue augmentation for more than a decade. In recent years, PAAG has been advocated as a safe soft tissue filler for facial augmentation. However, the complications associated with PAAG injection in facial augmentation have not been widely covered in the literature. We present two cases of severe complications associated with PAAG injection in facial augmentation, including bony erosion and facial ulcer. Further studies are required to support the safety of PAAG in facial injection. Copyright (c) 2009 British Association of Plastic, Reconstructive and Aesthetic Surgeons. Published by Elsevier Ltd. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19540824     DOI: 10.1016/j.bjps.2009.05.013

Source DB:  PubMed          Journal:  J Plast Reconstr Aesthet Surg        ISSN: 1748-6815            Impact factor:   2.740


  4 in total

1.  Facial gel complication after dental injection: a case report.

Authors:  Fereydoun Pourdanesh; Shahin Shams; Hasan Mir Mohammad Sadeghi
Journal:  Craniomaxillofac Trauma Reconstr       Date:  2013-08-29

2.  Quality of life after periurethral injection with polyacrylamide hydrogel for stress urinary incontinence.

Authors:  Gerda Trutnovsky; Karl Tamussino; Elfriede Greimel; Vesna Bjelic-Radisic
Journal:  Int Urogynecol J       Date:  2010-10-09       Impact factor: 2.894

3.  A Case of Special Complication following a Large Amount of Polyacrylamide Hydrogel Injected into the Epicranial Aponeurosis: Leukocytopenia.

Authors:  Li Rong; Shi-Jie Lan; Ying Shao; Zhe Chen; Duo Zhang
Journal:  Case Rep Med       Date:  2015-10-20

4.  Treatment of complications from polyacrylamide hydrogel breast augmentation.

Authors:  Wang Wei
Journal:  Exp Ther Med       Date:  2016-05-09       Impact factor: 2.447

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.